Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad, announced a 12% year-over-year revenue growth for ... Read More
CLSA sees major drop ahead for Ambuja Cements – Investors beware!
CLSA, a global brokerage firm, has maintained an 'Underperform' rating for Ambuja Cements Limited, predicting a potential 9% decline in the stock's value. CLSA's target ... Read More